[Source](https://github.com/mm80843/T3.5/blob/main/docs/index.md) -- [RiskMitigation](https://github.com/mm80843/T3.5/tree/main/docs/RiskMitigation/index.md) 

# RiskMitigation: __Tissue culture infectious dose at the 50% endpoint (TCID50) technique__ (PBN__Mitigation_850)

## Property: has_MitigationRisk


## Property: has_MitigationSource

* [ikner_continuously_2020](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_246.md)

## Property: has_MitigationTechnology

* [tcid50 technique](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_3493.md)

## Property: has_MitigationPrinciple

Determines viral titers in the test virus suspension

